Trial signals major milestone in hunt for new TB drugs

Lancet paper finds novel drug regimen could be more effective than existing treatments; TB Alliance’s trial to test drugs in combination saves years in research time.

Read More →

HIV i-Base/Treatment Action Group: 2012 Pipeline Report

Recent advances in biomedical HIV, hepatitis C virus, and tuberculosis prevention and treatment are not reaching those who need them most; Political leaders continue to break domestic, global health commitments.

Read More →

ACTION: The Global Fund: Progress at Risk

ACTION’s new publication, The Global Fund: Progress at Risk, provides specific examples of where the fight against TB will slow unless donors contribute needed resources.

Read More →

Advocates at the 2012 International AIDS Conference are mobilizing to fight TB and HIV

The We Can End AIDS Mobilization for Economic Justice and Human Rights is on Tuesday, July 24 at 12 noon. TB advocates should join the Sound Policies branch, leaving from the Archives Metro station (see map here: http://www.wecanendaids.org/map.html).

Read More →

TB/HIV at AIDS 2012, XIX International AIDS Conference

Read More →

African Union adopts new roadmap to accelerate progress in HIV, TB and malaria responses

The Roadmap offers a set of practical and African-owned solutions to enhance sustainable responses to AIDS, TB and malaria. 

Read More →

CDC Global Health Strategy 2012 - 2015

The strategy provides a clear definition of CDC's role in global health and will enable the agency to respond effectively to the evolving environment.

Read More →

UNITAID: Tuberculosis diagnostic technology landscape report

The report describes existing TB diagnostics and the pipeline of expected future methods and tools; characterizes unmet needs and the extent to which the pipeline may address these; and highlights areas of persisting market shortcomings.

Read More →

PEPFAR: Guidance on integrating TB screening into PMTCT/Pediatric HIV programs

The growing evidence regarding the burden and detrimental effects of TB among women and children, especially among those living with HIV, highlights the need for improving TB/HIV activities in PMTCT and maternal, newborn, and child health settings.

Read More →

EMA: Response to TB CAB letter

EMA's response to TB CAB letter regarding conducting drug-drug interaction studies for bedaquiline (TMC207) and delamanid (OPC6783).

Read More →

Page 78 of 88 · Total posts: 10

←First 77 78 79 Last→